Animal cells and systems

The Korean Society for Integrative Biology (한국통합생물학회)
권호 표지

Regulation of Prolactin Secretion: Dopamine is the Prolactin-release Inhibiting Factor (PIF), but also Plays a Role as a Releasing Factor (PRF)

  • Shin, Seon H. (Department of Physiology and Pharmacology, Queens University) ;
  • Song, Jin-Hyang (Department of Physiology and Pharmacology, Queens University) ;
  • Ross, Gregory M. (Department of Physiology and Pharmacology, Queens University)
  • Published : 1999.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Many in-depth reviews related to regulations of prolactin secretion are available. We will, therefore, focus on controversial aspects using personal opinion in this review. The neuroendocrine control of prolactin secretion from the anterior pituitary gland involves multiple factors including prolactin-release inhibiting factor (PIF) and prolactin releasing factor (PRF). The PIF exerts a tonic inhibitory control in the physiological conditions. The PIF should be able to effectively inhibit prolactin release or a lifetime, but the inhibitory action of dopamine cannot be sustained for a long period of time. Perifusion of a high concentration of dopamine (l ,000 nM) could not sustain inhibitory action on prolactin release but when a small amount of ascorbic acid (0.1 mM) is added in a low concentration of dopamine (3 nM) solution, prolactin release was inhibited for a long period. Ascorbate is essential for dopamine action to inhibit prolactin release. We have, therefore, concluded that the PIF is dopamine plus ascorbate. The major transduction system for dopamine to inhibit prolactin release is the adenylyl cyclase system. Dopamine decreases cyclic AMP concentration by inhibiting adenylyl cyclase, and cyclic AMP stimulates prolactin release. However, the inhibitory mechanism of dopamine on prolactin release is much more complex than simple inhibition of CAMP production. The dopamine not only inhibits cyclic AMP synthesis but also inhibits prolactin release by acting on a link(s) after the CAMP event in a chain reaction for inhibiting prolactin release. Low concentrations of dopamine stimulate prolactin release. Lactotropes are made of several different subtypes of cells and several different dopamine receptors are found in pituitary. The inhibitory and stimulatory actions induced by dopamine can be generated by different subtype of receptors. The GH$_4$ZR$_7$ cells express only the short isoform (D$_{2s}$) of the dopamine receptor, as a result of transfecting the D$_{2s}$ receptors into GH$_4$C$_1$ cells which do not express any dopamine receptors. When dopamine stimulates or inhibits prolactin release in GH$_4$ZR$_7$ cells, it is clear that the dopamine should act on dopamine D$_{2s}$ receptors since there is no other dopamine receptor in the GH$_4$ZR$_7$. Dopamine is able to stimulate prolactin release in a relatively low concentration while it inhibits in a high concentration in GH$_4$ZR$_7$. These observations indicate that the dopamine D$_2$ receptor can activate stimulatory and/or inhibitory transduction system depending upon dopamine concentrations.

Keywords

References

  1. J Biol Chem v.265 Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion Albert PR;Neve KA;Bunzow JR;Civelli O
  2. J Neurosci Res v.13 Modulation of anterior pituitary dopamine receptors by estradiol 17-beta: dose-response relationship Ali SF;Peck EJ, Jr
  3. Endocr Rev v.6 Dopamine: a prolactin-inhibiting hormone Ben-Jonathan N
  4. Prog Neurobiol v.33 Neuroendocrine regulation of prolactin release Ben-Jonathan N;Arbogast LA;Hyde JF
  5. Proc Soc Exp Biol Med v.136 The effect of median eminence (ME) lesions on plasma levels of FSH, LH, and prolactin in the rat Bishop W;Krulich L;Fawcett CP;McCann SM
  6. Neuroendocrinology v.42 Analysis by plaque assays of GH and prolactin release from individual cells in cultures of male pituitaries. Evidence for functional heterogeneity within rat mammotrope and somatotrope populations Boockfor FR;Hoeffler JP;Frawley LS
  7. Endocrinology v.99 Prolactin-releasing factor(PRF) in porcine hypothalamic extract distinct from TRH Boyd AE;Spencer E;Jackson IM;Reichlin S
  8. Endocrinology v.133 Low concentrations of dopamine increase cytosolic calcium in lactotrophs Burris TP;Freeman ME
  9. Endocrinology v.130 The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins Burris TP;Nguyen DN;Smith SG;Freeman ME
  10. Proc Soc Exp Biol Med v.205 Comparison of the forms of the dopamine D₂receptor expressed in GH₄C₁cells Burris TP;Freeman ME
  11. Neuroendocrinology v.54 Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland Burris TP;Stringer LC;Freeman ME
  12. Endocrine v.7 Dopamine D₂receptor mediates both inhibitory and stimulatory actions on prolactin release Chang A;Shin SH;Pang SC
  13. Endocrine v.7 Relationships between dopamine-induced changes in cytosolic free calcium concentration $([Ca^{2+}]i)$ and rate of prolactin secretion. Elevated $[Ca^{2+}]i$ does not indicate prolactin release Chang A;Shin SH
  14. Neuroendocrinology v.6 Serum prolactin levels in rats with pituitary transplants or hypothalamic lesions Chen CL;Amenomori Y;Lu KH;Voogt JL;Meites J
  15. Neuroendocrinology v.26 The effect of exposure to ether on prolactin secretion and the half-life of endogenous prolactin in normal and castrated male rats Chi HJ;Shin SH
  16. Mol Cell Endocrinol v.93 Progesterone inhibits the estrogen-induced prolactin gene expression in the rat pituitary Cho BN;Suh YH;Yoon YD;Lee CC;Kim K
  17. Annu Rev Pharmacol Toxicol v.33 Molecular diversity of the dopamine receptors Civelli O;Bunzow JR;Grandy DK
  18. Can J Physiol Pharmacol v.59 Somatostatin inhibits prolactin secretion in the estradiol primed male rat Cooper GR;Shin SH
  19. Endocrinology v.105 Secretion of dopamine into hypophysial portal blood by rats bearing prolactin-secreting tumors or ectopic pituitary glands Cramer OM;Parker CR Jr;Porter JC
  20. Endocrinology v.134 Calcium/calmodulin-dependent protein kinase-Ⅱ activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine Cui ZJ;Gorelick FS;Dannies PS
  21. EMBO J v.8 The dopamine D₂receptor: two molecular forms generated by alternative splicing Dal Toso R;Sommer B;Ewert M;Herb A;Pritchett DB;Bach A;Shivers BD;Seeburg PH
  22. Endocr Rev v.20 Protein hormone storage in secretory granules: mechanisms for concentration and sorting Dannies PS
  23. Nature v.285 Dopaminergic stimulation of prolactin release Denef C;Manet D;Dewals R
  24. Eur J Pharmacol v.41 Evidence in favour of the existence of a dopamine-free prolactin-inhibiting factor (PIF) in rat hypothalamic extracts Enjalbert A;Priam M;Kordon C
  25. Endocrinology v.105 Independent inhibition of prolactin secretion by dopamine and gamma-aminobutyric acid in citro Enjalbert A;Ruberg M;Arancibia S;Fiore L;Priam M;Kordon C
  26. Dopamine Receptors and Transporters Functional distinctions of dopamine D₂long and D₂short receptors Faladeau, P;Niznik K(ed.)
  27. Mol Endocrinol v.4 The homeodomain protein, Pit-1/GHF-1, is capable of binding to and activating cell-specific elements of both the growth hormone and prolactin gene promoters Fox SR;Jong MT;Casanova J;Ye ZS;Stanley F;Samuels HH
  28. Dis Mon v.22 Diseases of hypothalamic releasing factors Frohman LA
  29. J Neurochem v.56 Analysis of the structure and expression of the human dopamine D₂A receptor gene Gandelman KY;Harmon S;Todd RD;O'Malley KL
  30. Endocrinology v.111 Direct effects of sex steroids on prolactin release at the anterior pituitary level: interactions with dopamine, thyrotropin-releasing hormone, and isobutylemethylxanthine Giguere V;Meunier H;Veileux R;Labrie F
  31. Annu Rev Neurosci v.16 Recent advances in the molecular biology of dopamine receptors Gingrich JA;Caron MG
  32. Endocrinology v.104 Release of newly synthesized dopamine into the hypophysial portal vasculature of the rat Gudelsky GA;Porter JC
  33. Pharmacol Biochem Behav v.59 Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems Hall FS;Wilkinson LS;Humby T;Inglis W;Kendall DA;Marsden CA;Robbins TW
  34. Neuroendocrinology v.55 Differential inhibition of dopamine and bromocriptine on induced prolactin release: multiple sites for the inhibition of dopamine Hanna S;Shin SH
  35. Endocrinology v.111 Rat anterior pituitary dopaminergic receptors are regulated by estradiol and during lactation Heiman ML;Ben-Jonathan N
  36. J Cell Biol v.59 Hormone secretion by cells dissociated from rat anterior pituitaries Hopkins CR;Farquhar MG
  37. Endocrinology v.92 Enrichment of cell types from the rat adenohypophysis by sedimentation at unit gravity Hymer WC;Evans WH;Kraicer J;Mastro A;Davis J;Griswold E
  38. Endocrinology v.119 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells Kimura N;Hayafuji C;Konagaya H;Takahashi K
  39. Endocrinology v.135 Paradoxical effects of dopamine (DA): Gi alpha 3 mediates DA inhibition of PRL release while masking its PRL-releasing activity Kineman RD;Gettys TW;Frawley LS
  40. Endocrinology v.87 Biphasic effects of catecholamines on pituitary prolactin release in vitro Koch Y;Lu KH;Meites J
  41. Histochemistry v.92 Prolactin crinophagy is induced in the estrogen-stimulated male rat pituitary Kuriakose NR;Reifel CW;Bendayan M;Elce JS;Shin SH
  42. Physiol Rev v.70 Regulation of prolactin secretion at the level of the lactotroph Lamberts SW;MacLeod RM
  43. J Endocrinol v.148 Somatostatin does not inhibit prolactin synthesis in normal male rat pituitary cells but inhibits prolactin synthesis in estradiol-primed pituitary cells Lee SC;Shin SH
  44. Neuron v.8 Differential G protein-mediated coupling of D₂dopamine receptors to K^+\;and\;Ca6{2+}$ currents in rat anterior pituitary cells Lledo PM;Homburger V;Bockaert J;Vincent JD
  45. Brain Res v.506 Dopamine enhances a voltage-dependent transient $K^+$ current in the MMQ cell, a clonal pituitary line expressing functional D₂dopamine receptors Login IS;Pancrazio JJ;Kim YI
  46. Endocrinology v.118 Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine Luque EH;Munoz de Toro M;Smith PF;Neill JD
  47. Frontiers in Neuroendocrinology v.4 Regulation of prolactin secretion MacLeod RM
  48. Growth Hormone and Related Peptides Inhibition of prolactin secretion by dopamine and piribedil (ET-495) MacLeod RM;Kimura H;Login I;Pecile A(ed.);Muller EE(ed.)
  49. J Bio Chem v.262 Dopamine inhibits cytosolic $Ca^{2+}$ increases in rat lactotroph cells. Evidence of a dual mechanism of action Malgaroli A;Vallar L;Elahi FR;Pozzan T;Spada A;Meldolesi J
  50. Can J Physiol Pharmacol v.62 Stability of dopamine in an in vitro incubation system using Medium 199 Marien MR;Shin SH;Cooper GR;Jhamandas K
  51. Pharmacol Res Commun v.11 Stress-induced hypertension and COMT activity in rats Maura G;Versace P;Paudice P
  52. Endocrinology v.99 Effect of suckling on plasma prolactin and hypothalamic monoamine levels in the rat Mena F;Enjalbert A;Carbonell L;Priam M;Kordan C
  53. Endocrinology v.115 Effects of thyrotropin-releasing hormone on prolactin compartments in clonal rat pituitary tumor cells Morin A;Rosenbaum E;Tixier-Vidal A
  54. Recent Prog Horm Res v.43 Detection and measurement of hormone secretion from individual pituitary cells Neill JD
  55. J Clin Endocrinol Metab v.30 Evidence of independent secretion of prolactin and growth hormone in vitro by adenohypophyses of rhesus monkeys Nicoll CS;Parsons JA;Fiorindo RP;Nichols CW Jr;Sakuma M
  56. Science v.189 Intracellular aspects of the process of protein synthesis Palade G
  57. Proc Roy Soc B v.154 A theory of drug action based on the rate of drug-receptor combination Paton, WDM
  58. Neuroendocrinology v.63 Beta-endorphin, but not oxytocin, substance P or vasoactive- intestinal polypeptide, contributes to progesterone-induced prolactin secretion in monkeys Pecins-Thompson M;Widmann AA;Bethea CL
  59. Mol Cell Endocrinol v.21 Newly synthesized prolactin is preferentially secreted by the adenohypophysis in a primary cell culture system Piercy M;Shin SH
  60. Endocrinology v.102 Liquid chromatographic-electrochemical measurement of dopamine in hypophysial stalk blood of rats Plotsky PM;Gibbs DM;Neill JD
  61. Neuroendocrinology v.13 The effect of catecholamines on hormone release from anterior pituitaries and ventral hypothalami incubated in vitro Quijada M;Illner P;Krulich L;McCann SM
  62. Science v.200 Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release Raymond V;Beaulieu M;Labrie F;Boissier J
  63. Cell Tissue Res v.232 Extensive ultrastructural changes in rat mammotrophs following administration of the dopamine agonist ergocristine-reflecting inhibition of prolactin release Reifel CW;Shin SH;Leather RA
  64. Neuroendocrinology v.36 Dopamine creates a physical barrier to inhibit prolactin release in mammotrophs of estradiol-primed male rats Reifel CW;Saunders SL;Shin SH
  65. Endocrinology v.119 Evidence for a physiological role for oxytocin in the control of prolactin secretion Samson WK;Lumpkin MD;McCann SM
  66. Acta Anat v.114 Desmosomes between mammotrophs suggest the existence of a functional syncytium Saunders SL;Reifel CW;Shin SH
  67. Endocrinology v.100 Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro Schally AV;Redding TW;Arimura A;Dupont A;Linthicum GL
  68. N Eng J Med v.314 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises Scully RE
  69. Endocrinology v.104 The differential stimulatory effect of thyroid hormone on growth hormone synthesis and estrogen on prolactin synthesis due to accumulation of specific messenger ribonucleic acids Seo H;Refetoff S;Martino E;Vassart G;Brocas H
  70. Life Sci v.23 Thyrotropin releasing hormone (TRH) is not the physiological prolactin releasing factor (PRF) in the male rat Shin SH
  71. Life Sci v.22 Dopamine-induced inhibition of prolactin release from cultured adenohypophysial cells: spare receptors for dopamine Shin SH
  72. Life Sci v.25 Prolactin secretion in acute stress is controlled by prolactin releasing factor Shin SH
  73. Neuroendocrinology v.31 Physiological evidence for the existence of prolactin releasing factor: stress-induced prolactin secretion is not linked to dopaminergic receptors Shin SH
  74. Neuroendocrinology v.34 Vasopressin has a direct effect on prolactin release in male rats Shin SH
  75. Neuroendocrinology v.57 Activation of the adrenergic beta-receptor stimulates prolactin release from primary cultured pituitary cells Shin SH;Barton RE
  76. Neuroendocrinology v.28 Unsuppressed prolactin secretion in the male rat is pulsatile Shin SH;Chi HJ
  77. Can J Physiol Pharmacol v.68 Reexamination of dopamine as the prolactin-release inhibiting factor (PIF): supplementary agent may be required for dopamine to function as the physiological PIF Shin SH;Hanna SF;Hong M;Jhamandas K
  78. Neuroendocrinology v.56 Phenoxybenzamine selectively and irreversibly inactivates dopaminergic D2 receptors on primary cultured rat lactotrophs Shin SH;McAssey K;Heisler RL;Szabo MS
  79. Horm Res v.9 Gamma-amino-butyric acid is not likely a physiological prolactin-inhibiting factor Shin SH;Obonsawin MC;Bates L
  80. Neuroendocrinology v.41 Bovine neurophysin Ⅱ has prolactin-releasing activity in the estradiol-primed male rat Shin SH;Obonsawin MC
  81. Can J Physiol Pharmacol v.65 Current status of the rat prolactin releasing factor Shin SH;Papas S;Obonsawin MC
  82. Am J Physiol v.273 Dopamine requires ascorbic acid to be the prolactin release-inhibiting ractor Shin SH;Si F;Chang A;Ross GM
  83. Endocrinol Exp v.24 Ascorbic acid potentiates the inhibitory effect of dopamine on prolactin release: a putative supplementary agent for PIF Shin SH;Stirling RG;Hanna S;Lim M;Wilson JX
  84. Endocrinology v.114 Estrogen stimulates prolactin gene transcription by a mechanism independent of pituitary protein synthesis Shull JD;Gorski J
  85. J Cell Biol v.31 Lysosome function in the regulation of the secretory process in cells of the anterior pituitary gland Smith RE;Farquhar MG
  86. Endocrinology v.101 Functional hetero geneity in somatotrophs isolated from the rat anterior pituitary Snyder G;Hymer WC;Snyder J
  87. Endocrinology v.124 Estrogen and progestin receptor immunocytochemistry in lactotropes versus gonadotropes of monkey pituitary cell cultures Sprangers SA;Brenner RM;Bethea CL
  88. Mol Cell Endocrinol v.70 A high concentration of dopamine preferentially permitted release of newly synthesized prolactin Stirling RG;Shin SH
  89. Endocrinology v.89 heterogeneous turnover of adenohypophysial prolactin Swearingen KC
  90. Endocrinology v.98 Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat Tannenbaum GS;Martin JB
  91. J Cell Biol v.79 Comparative studies of intracellular transport of secretory proteins Tartakoff A;Vassalli P;Detraz M
  92. Methods Enzymol v.58 Clonal strains of hormone-producing pituitary cells Tashjian AH Jr
  93. Endocrinology v.93 TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro Vale W;Blackwell R;Grant G;Guillemin R
  94. Endocrinology v.91 Prolactin-releasing factor in porcine and rat hypothalamic tissue Valverde RC;Chieffo V;Reichlin S
  95. Endocrinology v.107 preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs Walker AM;Farquhar MG
  96. Mol Pharmacol v.49 D₂, D₃, and D₄dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes Werner P;Hussy N;Buell G;Jones KA;North RA
  97. Endocrinology v.106 Effects of estradiol on prolactin production and dihydroergocryptine0induced inhibition of jprolactin production in primary cultures of rat pituitary cells West B;Dannies PS
  98. J Clin Endocrinol Metab v.60 hyperprolactinemia induced by an estrogen-progesterone synergy: quantitative and temporal effects of estrogen priming in monkeys Williams RF;Gianfortoni JG;Hodgen GD
  99. Science v.182 Vasopressin and neurophysin: high concentration in monkey hypophyseal portal blood Zimmerman EA;Carmel PW;Husain MK;Ferin M;Tennenbaum M;Frantz AG;Robinson AG
  100. Endocrinology v.86 Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats Chen CL;Meites J